ConductScience.org, home

Trial · NCT07174167

Genicular Nerve Block in Chronic Knee Osteoarthritis

NCT07174167, Not applicable, Completed, Haydarpasa Numune Training and Research Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Genicular Nerve Block in Chronic Knee Osteoarthritis. Trials, record NCT07174167. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07174167

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Genicular Nerve Block in Chronic Knee Osteoarthritis
NCT number
NCT07174167
Status
Completed
Phases
Not applicable
Enrollment
81 participants, actual
Lead sponsor
Haydarpasa Numune Training and Research Hospital
Conditions
Gonarthrosis; Primary, Genicular Nerve Block, Gonarthritis
Interventions
Genicular nerve block with prilocaine, genicular nerve block with prilocaine and triamcinolone, Sham injection
First posted
2025-09-15
Last updated
2025-11-28

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPain intensityat baseline, 1 week, and 1 month after treatmentVisual Analog Scale (VAS): The VAS assesses pain intensity on a 10-centimeter scale. Patients indicate their pain levels using two verbal descriptors at the end of each scale.
SecondaryFunctional status using WOMACbaseline, 1 week, and 1 month after treatmentThe Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire assessed pain and disability.
SecondaryFunctional status using 40-Meter Fast Walking Testat baseline, 1 week, and 1 month after treatment
40-Meter Fast Walking Test: This test involved a designated 10-meter walking track. Patients walked at their maximum pace for four laps. No warm-up was conducted, and the time spent turning at the lines was excluded from the calculation
SecondaryPressure Pain Threshold (PPT)baseline, 1 week, and 1 month after treatment
Pressure Pain Threshold (PPT): The Commander Algometer (JTECH Medical, Utah, USA) was utilized to measure PPT at both the medial and lateral sides of the patella. The probe tip of the algometer was applied perpendicularly to the skin, and pressure was gradually increased. Patients indicated when they first experienced discomfort, at which point the measurement was recorded. This procedure was repeated three times, and the average value was noted.
OtherUltrasound evaluationbaselineUltrasound measurements were taken to assess patellofemoral cartilage thickness and quadriceps muscle thickness

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
29357330BACKGROUNDPubMed
30921977BACKGROUNDPubMed
36369781BACKGROUNDPubMed
39901967BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07174167

GET https://conductscience.org/api/trials/v1/NCT07174167/registered